Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
970 | 10197 | 27.9 | 61% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
35 | 104217 | STATISTICS & PROBABILITY//COMMUNICATIONS IN STATISTICS-THEORY AND METHODS//STAT |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CAUSAL INFERENCE | Author keyword | 356 | 53% | 5% | 466 |
2 | PRINCIPAL STRATIFICATION | Author keyword | 314 | 94% | 1% | 111 |
3 | STATISTICS IN MEDICINE | Journal | 298 | 20% | 13% | 1336 |
4 | ADAPTIVE DESIGN | Author keyword | 296 | 69% | 2% | 253 |
5 | CONTINUAL REASSESSMENT METHOD | Author keyword | 199 | 90% | 1% | 85 |
6 | CONDITIONAL POWER | Author keyword | 178 | 88% | 1% | 83 |
7 | INTERIM ANALYSIS | Author keyword | 156 | 69% | 1% | 135 |
8 | SAMPLE SIZE RE ESTIMATION | Author keyword | 152 | 93% | 1% | 56 |
9 | GROUP SEQUENTIAL DESIGN | Author keyword | 114 | 88% | 1% | 53 |
10 | INTERIM ANALYSES | Author keyword | 113 | 92% | 0% | 45 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CAUSAL INFERENCE | 356 | 53% | 5% | 466 | Search CAUSAL+INFERENCE | Search CAUSAL+INFERENCE |
2 | PRINCIPAL STRATIFICATION | 314 | 94% | 1% | 111 | Search PRINCIPAL+STRATIFICATION | Search PRINCIPAL+STRATIFICATION |
3 | ADAPTIVE DESIGN | 296 | 69% | 2% | 253 | Search ADAPTIVE+DESIGN | Search ADAPTIVE+DESIGN |
4 | CONTINUAL REASSESSMENT METHOD | 199 | 90% | 1% | 85 | Search CONTINUAL+REASSESSMENT+METHOD | Search CONTINUAL+REASSESSMENT+METHOD |
5 | CONDITIONAL POWER | 178 | 88% | 1% | 83 | Search CONDITIONAL+POWER | Search CONDITIONAL+POWER |
6 | INTERIM ANALYSIS | 156 | 69% | 1% | 135 | Search INTERIM+ANALYSIS | Search INTERIM+ANALYSIS |
7 | SAMPLE SIZE RE ESTIMATION | 152 | 93% | 1% | 56 | Search SAMPLE+SIZE+RE+ESTIMATION | Search SAMPLE+SIZE+RE+ESTIMATION |
8 | GROUP SEQUENTIAL DESIGN | 114 | 88% | 1% | 53 | Search GROUP+SEQUENTIAL+DESIGN | Search GROUP+SEQUENTIAL+DESIGN |
9 | INTERIM ANALYSES | 113 | 92% | 0% | 45 | Search INTERIM+ANALYSES | Search INTERIM+ANALYSES |
10 | ADAPTIVE DESIGNS | 112 | 72% | 1% | 88 | Search ADAPTIVE+DESIGNS | Search ADAPTIVE+DESIGNS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CAUSAL INFERENCE | 348 | 48% | 5% | 528 |
2 | CONTINUAL REASSESSMENT METHOD | 261 | 66% | 2% | 241 |
3 | INTERIM ANALYSES | 184 | 82% | 1% | 108 |
4 | BIASED COIN DESIGNS | 174 | 90% | 1% | 77 |
5 | CONDITIONAL POWER | 157 | 91% | 1% | 64 |
6 | PRINCIPAL STRATIFICATION | 136 | 72% | 1% | 108 |
7 | SAMPLE SIZE REESTIMATION | 118 | 95% | 0% | 39 |
8 | GROUP SEQUENTIAL DESIGNS | 103 | 91% | 0% | 42 |
9 | PROPENSITY SCORE | 100 | 17% | 5% | 524 |
10 | HYPOTHESES SELECTION | 91 | 94% | 0% | 32 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STATISTICS IN MEDICINE | 298 | 20% | 13% | 1336 |
2 | JOURNAL OF BIOPHARMACEUTICAL STATISTICS | 91 | 31% | 2% | 249 |
3 | CLINICAL TRIALS | 78 | 32% | 2% | 203 |
4 | PHARMACEUTICAL STATISTICS | 78 | 37% | 2% | 167 |
5 | BIOMETRICS | 57 | 11% | 5% | 481 |
6 | CONTROLLED CLINICAL TRIALS | 53 | 22% | 2% | 213 |
7 | INTERNATIONAL JOURNAL OF BIOSTATISTICS | 34 | 37% | 1% | 75 |
8 | STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 28 | 31% | 1% | 76 |
9 | DRUG INFORMATION JOURNAL | 22 | 14% | 1% | 152 |
10 | CONTEMPORARY CLINICAL TRIALS | 20 | 13% | 1% | 144 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Matching Methods for Causal Inference: A Review and a Look Forward | 2010 | 314 | 80 | 94% |
Mediation analysis | 2007 | 1263 | 58 | 48% |
Net Reclassification Indices for Evaluating Risk Prediction Instruments A Critical Review | 2014 | 32 | 12 | 67% |
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis | 2010 | 154 | 16 | 88% |
Recent Developments in the Econometrics of Program Evaluation | 2009 | 427 | 172 | 44% |
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research | 2013 | 62 | 69 | 43% |
Adaptive clinical trials in oncology | 2012 | 45 | 13 | 85% |
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker | 2012 | 86 | 58 | 47% |
An overview of the objectives of and the approaches to propensity score analyses | 2011 | 76 | 13 | 77% |
How to Use a Subgroup Analysis | 2014 | 30 | 20 | 30% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED PHARMACEUT STAT UNIT | 55 | 56% | 0.7% | 67 |
2 | TUFTS CTSI | 23 | 100% | 0.1% | 10 |
3 | BIOMETR 1 | 19 | 50% | 0.3% | 28 |
4 | QUANTITAT DECIS STRATEGIES | 18 | 89% | 0.1% | 8 |
5 | SWISS EMPIR ECON SEW | 17 | 72% | 0.1% | 13 |
6 | BIOMETR BRANCH | 15 | 16% | 0.8% | 85 |
7 | MED BIOMETRY UNIT | 13 | 71% | 0.1% | 10 |
8 | BIOMETR 5 | 7 | 53% | 0.1% | 9 |
9 | ENVIRONM MED BEHAV SCI | 6 | 48% | 0.1% | 10 |
10 | SECT QUANTITAT BIOL PL STAT | 6 | 80% | 0.0% | 4 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000020691 | REGRESSION CALIBRATION//MEASUREMENT ERROR//ERRORS IN VARIABLES |
2 | 0.0000020480 | MULTIPLE IMPUTATION//LIFETIME DATA ANALYSIS//STATISTICS IN MEDICINE |
3 | 0.0000019198 | FAMILYWISE ERROR RATE//MULTIPLE TESTING//FALSE DISCOVERY RATE |
4 | 0.0000015882 | EFFECT SIZE//NHST//NULL HYPOTHESIS SIGNIFICANCE TESTING |
5 | 0.0000012797 | DOUBLE DATA ENTRY//RISK BASED MONITORING//SOURCE DATA VERIFICATION |
6 | 0.0000009875 | EVIDENCE BASED MEDICINE//BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION//PUBLICATION BIAS |
7 | 0.0000007474 | TOTAL DEVIATION INDEX//CONCORDANCE CORRELATION COEFFICIENT//COHENS KAPPA |
8 | 0.0000007234 | VERIFICATION BIAS//TRACER GAS TEST//PARTIAL VERIFICATION |
9 | 0.0000006846 | INFORMED CONSENT//RESEARCH ETHICS//MEDICAL ETHICS |
10 | 0.0000006143 | STRUCTURAL EQUATION MODELING-A MULTIDISCIPLINARY JOURNAL//MULTIVARIATE BEHAVIORAL RESEARCH//COEFFICIENT ALPHA |